# FDA recall D-1847-2019

> **American Health Packaging** · Class III · drug recall initiated 2019-08-27.

## Product

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH

## Reason for recall

Labeling: Incorrect or Missing Package Insert; an error in the  Dosage Forms and Strengths  section of the insert that incorrectly lists the tablet description coding for the tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1847-2019
- **Recalling firm:** American Health Packaging
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-27
- **Report date:** 2019-09-18
- **Termination date:** 2020-09-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1847-2019

## Citation

> AI Analytics. FDA recall D-1847-2019. Retrieved 2026-07-04 from https://api.ai-analytics.org/recall/D-1847-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*